Erythropoietin in the Treatment of Anemia After Autologous Hematopoietic Stem Cell Transplantation
Status:
Unknown status
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
This is an randomized trial to evaluate the potential benefit of erythropoietin in the
treatment of anemia in patients with lymphoma after autologous hematopoietic stem cell
transplantation.
Phase:
Phase 4
Details
Lead Sponsor:
Peking University
Treatments:
Epoetin Alfa Ferrous succinate Folic Acid Hematinics Hydroxocobalamin Vitamin B 12 Vitamin B Complex Vitamins